No evidence of metastatic disease means your latest tests found no cancer that has spread to other parts of your body.1Brown University Health. What Does No Evidence of Metastatic Disease Mean? After treatment, it is one of the best results a scan report can give, and many people who hear it stay well. It describes what today’s tests can see, not a promise about the future, which is why doctors pair it with continued check-ups.
How NED Differs From Remission, Cancer-Free and Cured
Your report or doctor may write NED, short for no evidence of disease. It means nothing cancerous shows on scans or blood tests right now.2Brown University Health. What Does No Evidence of Metastatic Disease Mean? Doctors often use NED and complete remission to mean the same thing.3Brown University Health. What Does No Evidence of Metastatic Disease Mean?4UT MD Anderson. Remission, cancer-free, no evidence of disease: What’s the difference? Cancer-free goes further. It implies that no cancer cells remain anywhere and that the cancer will not return, which no test can measure.5UT MD Anderson. Remission, cancer-free, no evidence of disease: What’s the difference?
The word “metastatic” refers to cancer that has spread beyond where it started. The phrase usually means doctors looked for spread and found none. A radiologist describing a scan often writes “no evidence of metastatic disease,” while an oncologist may say “remission” in the clinic.
Remission comes in degrees. Partial remission means the cancer has shrunk but some remains, while complete remission means nothing detectable is left. A report that says NED describes the complete version, so it is worth checking which kind your doctor means if the wording is unclear. Some blood cancers use their own response terms, such as “complete response,” that carry the same basic meaning.
Cured is a word for later. Most cancer doctors hold it back until years of follow-up have passed without a return.6Burzynski Clinic. Remission vs No Evidence of Disease One cancer doctor tells patients they are likely cured after about five years of NED, because recurrence after that point is so unlikely for many cancers.7Brown University Health. What Does No Evidence of Metastatic Disease Mean? Some cancers, such as breast cancer, can still return later than five years.8PubMed Central. The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis Follow-up is routine for everyone with NED, not a sign that doctors suspect a problem.
Why Scans Can Miss Very Small Cancer
A typical PET scan can reliably pick up a tumor about 7 mm across, roughly the size of a pea.9PubMed Central. Limits of Tumor Detectability in Nuclear Medicine and PET Clusters of a few thousand cells are far smaller than that and invisible to it, so leftover cells after treatment can exist for a time without producing any image. Experts agree current imaging cannot detect the small traces left after surgery or chemotherapy.10PubMed. Minimal residual disease as a target for liquid biopsy in patients with solid tumours
Lymph nodes show the problem well. A node can hold a tiny cancer deposit while staying normal in size, so an ordinary-looking node is not proof it is clear. In high-risk prostate cancer, an advanced PSMA PET scan found only about 3 in 10 lymph nodes that actually held cancer, missing mostly tiny ones.11PubMed. 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer That is why surgeons sometimes remove nodes and examine them under a microscope, which sees what imaging cannot.
Different scans also see different things. CT and MRI show the shape and size of tissue, while PET shows how active cells are, so each has its own blind spots. Doctors choose the scan that best suits your cancer type, which is why you may get a different one than a friend with another cancer. Sometimes two are combined, as in PET/CT, so activity can be matched to an exact location.
Slow cancers can hide too. PET scans light up cells that burn a lot of sugar, so slow-growing, low-activity tumors can look normal.12PubMed Central. False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases In primary breast cancer, tumors 10 mm or smaller and low-grade tumors were the ones PET most often missed.13PubMed. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer
Some cells simply sleep. Cancer cells that spread can enter a dormant state, staying alive but not dividing, sometimes for years.14PubMed Central. Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer In breast cancer, signals in bone can hold such cells in this resting state.15PubMed Central. Breast Cancer Dormancy in Bone This helps explain how cancer can return long after clear scans.
Tests That Back Up or Go Beyond Scans
Some cancers release substances into the blood, called tumor markers on your lab report, such as CA 15-3 for breast cancer or CEA for colon cancer.16PubMed. Serum tumor markers and PET/CT imaging for tumor recurrence detection A tumor marker blood test measures that substance, and a rising level can hint that cancer cells are active somewhere. A rising marker with no symptoms can lead doctors to order a PET/CT even after earlier scans were clear.17PubMed. Serum tumor markers and PET/CT imaging for tumor recurrence detection After a rising marker in breast cancer, PET/CT correctly confirmed or ruled out a return in about 9 of 10 people.18PubMed. Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management If that scan is clear, doctors typically keep watching and repeat the marker rather than start treatment on the number alone.
A tumor marker result has limits. Not every cancer releases a useful marker, and some people with active cancer have normal levels. Markers can also rise for harmless reasons such as infection or inflammation, so a high number is a prompt to look further, not a diagnosis. Doctors usually watch the trend across several tests rather than a single reading.
A newer blood test looks for tiny fragments of tumor DNA, often listed as ctDNA, to find leftover cancer.19PubMed. Minimal residual disease as a target for liquid biopsy in patients with solid tumours These are genetic pieces shed by cancer cells, which scans cannot see directly. In metastatic breast cancer, the test sometimes turned negative months before scans showed NED, and sometimes flagged a return about a month before scans did.20Journal of Clinical Oncology. Minimal residual disease ctDNA testing in metastatic breast cancer patients with no radiological evidence of disease: Potentialclinical utility from real-worlddata That early warning is the main reason researchers are interested. But many US insurers treat these tests as experimental and do not cover them.21PubMed Central. Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care The tumor DNA blood test is not yet a standard part of follow-up for most cancers, so a negative result should not replace scheduled scans.
A few questions are worth bringing to your visit: whether your cancer type has a useful tumor marker blood test, whether a tumor DNA blood test would change your follow-up plan, and what insurance covers and what you would pay out of pocket before testing.
Can the Cancer Come Back After NED
It can, and the risk varies hugely. Across cancer types, between about 6% and 35% of people saw their cancer return.22PubMed. Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice That range covers many cancers, stages, and treatments, so it describes a spread across groups, not a prediction for one person. A small early tumor that was fully removed carries a very different risk from an advanced cancer that responded to drugs. In locally advanced head and neck cancer, about half of people who were clinically free of disease had a return within 5 years.23Cancer. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy
For most cancers, the risk rises most in the first 3 years and then levels off, but not for breast cancer.24PubMed. Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice That is why scans and visits are packed closest together early on. As years pass without a return, visits usually become less frequent, which reflects falling risk and not less care.
Breast cancer has a long tail. Among women free of breast cancer for 10 years, about 1 in 12 had a return by 15 years after diagnosis.25PubMed Central. The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis That rose to about 1 in 6 by 32 years.26PubMed Central. The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis Dormant cells in places like bone are one explanation for such late returns, and some hormone-driven breast cancers are treated with long-term medicine partly to reduce this risk. Breast cancer survivors often stay on longer follow-up than others.
How you reached NED matters too. When surgery after chemotherapy finds no cancer left in the removed breast and lymph nodes, survival is much better; your report may call this a pathologic complete response (pCR).27PubMed. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis The link is strongest in triple-negative and HER2-positive breast cancer.28PubMed. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis For metastatic melanoma, many people with complete remission on pembrolizumab stayed in remission about 2 years after stopping it.29PubMed. Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma And when cancer has spread to only a few spots, targeted radiation controls the treated spots in about 95% of people at one year.30JAMA Oncology. Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer: A Systematic Review and Meta-analysis Ask your doctor for your risk based on your cancer type, stage, and response.
What Follow-Up Looks Like Now
Schedules follow guidelines. After curative treatment for lung cancer, guidelines advise a chest CT every 6 months for 2 years, then yearly.31PubMed. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline Your own plan depends on your cancer, its stage, and how it was treated. Spacing out scans balances catching a return early against the downsides of too much imaging, such as radiation and false alarms.
Follow-up plans include regular visits and teaching you which symptoms to report.32PubMed. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) Catching a return early can allow treatment that may still cure it.33PubMed. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) A visit usually includes a conversation about symptoms, a physical exam, and sometimes blood tests. Scans are added according to your cancer type and risk, not at every visit.
Not every bright spot is cancer. Scans can light up from infection or inflammation.34PubMed Central. Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging After treatment, up to 40% of PET activity can come from non-cancer tissue.35PubMed Central. Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging So a new spot often leads to another scan or biopsy before any conclusion.
A little preparation helps. Write down any new pain, cough, lumps, or fatigue lasting over two weeks. Ask when results will come and how you’ll be told, and keep a copy of each report to compare over time. Tell the team about recent infections before PET scans.
Lowering the Chance of a Return
In cancer survivors, exercise programs roughly halved recurrence risk in a small set of trials.36PubMed Central. Effect of Exercise on Mortality and Recurrence in Patients With Cancer: A Systematic Review and Meta-Analysis That makes the finding encouraging but not settled. After colon cancer treatment, 150 minutes a week of aerobic exercise lowered cancer cells in the blood.37PubMed Central. Physical Activity Reduces The Risk of Recurrence and Mortality in Cancer Patients That suggests a possible mechanism but does not by itself prove fewer returns.
Aerobic exercise is anything that raises your heart rate and breathing for a sustained time, such as brisk walking, cycling, or swimming. A useful check is that you can talk but not sing. The 150 minutes works out to about 30 minutes, five days a week, and you can split it into shorter sessions, such as three 10-minute walks in a day. If treatment left you tired, start slower and build up, and ask your team about any limits after surgery or radiation.
Lower-fat diets may lower breast cancer recurrence, mostly through weight loss.38PubMed Central. Reducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and Exercise The benefit appears tied to weight, not to a single food or special diet. No specific food has been shown to prevent a return, so be cautious about products promising to do so.
Coping With Worry Before Scans
Over half of people with advanced cancer feel anxiety around scans.39PubMed. Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey It peaks while waiting for results.40PubMed. Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey Each extra day of waiting raised the odds of strong anxiety.41PubMed. Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study The days between scan and result are hard because there is nothing to do but wait, so asking for results as soon as possible, such as a same-day appointment, is worth it.
Clear explanations, information, and social support lowered anxiety.42PubMed. Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study Ask your team what the scan will show and what each possible result would lead to. Knowing when and how you will hear results removes part of the uncertainty, and a plan for what happens next, whatever the result, can make waiting easier. Asking staff to explain each step of the scan can help on the day itself.
Bring someone to the visit for support, and tell a friend or relative the date of your scan so they can be available that week. A support group, in person or online, lets you talk with people who have lived through the same wait. Plan distractions for the waiting days. If worry starts to disrupt sleep or daily life, tell your care team, since many cancer centers offer counseling.